The focus on treating rare diseases, the development of innovative vaccines and therapies, changes in regulations, increased investments into R&D, and the use of advanced technology are driving the growth of the biotech sector. Ongoing innovations in the biotech space meet demands for advanced healthcare, especially for chronic and aging-related conditions.
Amid this backdrop, investors could consider buying fundamentally strong biotech stocks: United Therapeutics Corporation (UTHR), TRACON Pharmaceuticals, Inc. (TCON), and Corcept Therapeutics Incorporated (CORT).
